Molecular EQA for Infectious Disease Testing
QCMD is a world leading External Quality Assessment (EQA) / Proficiency Testing (PT) scheme, dedicated to improving the quality of molecular diagnostic assays used in the detection of infectious diseases. With an extensive database of over 2000 participants in over 100 countries, QCMD is one of the largest providers of molecular EQA in the field of molecular diagnostics.
FEATURES & BENEFITS
Features | Benefits |
|---|---|
| Frequency | A variety of program options are available. Choose the number of challenges that best suit your laboratory’s requirements. |
| Online EQA Management System | ITEMS provides an online tool to easily manage all EQA activities from program registration to submission of results and provision of EQA reports. Different levels of user access are available so data can be accessed by whoever needs it. |
| High level of participation | Over 2000 participants in more than 100 countries ensuring peer group numbers are maximized. |
| Comprehensive reports | Receive individual reports for each challenge and a final supplementary report at the end of the cycle. |
| International accreditation | Programs are accredited to ISO 17043. |
EQA PROGRAMS
Blood Borne Viruses
Central Nervous System Diseases
Drug Resistance
Exotic / Emerging Diseases
Gastrointestinal Diseases
Immunocompromised Associated Diseases
Multiple Pathogen / Syndromic Infections
Respiratory Diseases
Serology
Sexually Transmitted Infections
Transplant Associated diseases
Typing
New Pilot Studies
REPORTS AND FEEDBACK
After the close of the results return phase, EQA participants will receive an individual report outlining their performance relative to their method and technology groups. A supplementary report may be commissioned – this includes any additional relevant information regarding the annual EQA distribution, as well as scientific expert commentary and feedback on the overall results within that distribution.
